Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: Rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study

Annals of the Rheumatic Diseases

Volumn 68, Issue 9, 2009, Pages 1506-1508

  Venhoff, N ^a   Rizzi, M ^a   Salzer, U ^a   Bossaller, L ^a   Thoden, J ^a   Eibel, H ^a   Walker, U A ^b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DIAZEPAM; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN; PARACETAMOL; PLACEBO; PREDNISOLONE; RITUXIMAB; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADULT; AUTOIMMUNE THYROIDITIS; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HASHIMOTO DISEASE; HUMAN; LETTER; MALE; MONOZYGOTIC TWINS; MUSCLE SPASM; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIFF MAN SYNDROME; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; CROSS-OVER STUDIES; DISEASES IN TWINS; DOUBLE-BLIND METHOD; HUMANS; MALE; STIFF-PERSON SYNDROME; THYROIDITIS, AUTOIMMUNE; TREATMENT FAILURE; TWINS, MONOZYGOTIC;

EID: 69949186255     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.103721     Document Type: Letter

References (9)

1. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin Exp Immunol 2004;137:225-233
2. Helfgott SM. Stiff-man syndrome: from the bedside to the bench. Arthritis Rheum 1999;42:1312-1320
3. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-1020 (Pubitemid 18095005)
4. Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, et al. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J Immunol 2005;175:7755-7762 (Pubitemid 41715229)
5. Dinkel K, Meinck HM, Jury KM, Karges W, Richter W. Inhibition of gammaaminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998;44:194-201. (Pubitemid 28374107)
6. Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000;55:1531-1535
7. Meinck HM, Ricker K, Conrad B. The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine. J Neurol Neurosurg Psychiatry 1984;47:280-287 (Pubitemid 14160403)
8. Baker MR, Das M, Isaacs J, Fawcett PR, Bates D. Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatry 2005;76:999-1001.
9. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008;358:676-688 (Pubitemid 351240747)